Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728524 | SCV000856111 | pathogenic | not provided | 2017-08-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000781669 | SCV000919892 | pathogenic | Niemann-Pick disease, type C | 2017-12-29 | criteria provided, single submitter | clinical testing | Variant summary: The NPC1 c.2819C>T (p.Ser940Leu) variant involves the alteration of a conserved nucleotide and 5/5 in silico tools predict a damaging outcome for this variant. This variant was found in 3/244918 control chromosomes (gnomAD) at a frequency of 0.0000122, which does not exceed the estimated maximal expected allele frequency of a pathogenic NPC1 variant (0.0027735). Multiple publications have cited the variant in affected homozygote and compound heterozygote individuals. In addition, a clinical diagnostic laboratory classified this variant as likely pathogenic. Taken together, this variant is classified as pathogenic. |
Centre for Mendelian Genomics, |
RCV000169010 | SCV001369023 | pathogenic | Niemann-Pick disease, type C1 | 2019-10-22 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PM3,PP3,PP5. |
Myriad Genetics, |
RCV000169010 | SCV002060174 | pathogenic | Niemann-Pick disease, type C1 | 2021-11-11 | criteria provided, single submitter | clinical testing | NM_000271.4(NPC1):c.2819C>T(S940L) is a missense variant classified as pathogenic in the context of Niemann-Pick disease type C1. S940L has been observed in cases with relevant disease (PMID: 26981555, 11349231, 25425405, 21245028, 16126423, 23146215, 16720792, 30285904, 26790753). Functional assessments of this variant are not available in the literature. S940L has been observed in population frequency databases (gnomAD: AFR 0.01%). In summary, NM_000271.4(NPC1):c.2819C>T(S940L) is a missense variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. |
Labcorp Genetics |
RCV000169010 | SCV002175947 | pathogenic | Niemann-Pick disease, type C1 | 2024-12-10 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 940 of the NPC1 protein (p.Ser940Leu). This variant is present in population databases (rs143124972, gnomAD 0.003%). This missense change has been observed in individual(s) with Niemann-Pick disease type C (PMID: 26790753, 28105569, 28710748, 32138288). ClinVar contains an entry for this variant (Variation ID: 188716). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Mayo Clinic Laboratories, |
RCV000728524 | SCV004226692 | likely pathogenic | not provided | 2022-05-03 | criteria provided, single submitter | clinical testing | PP1, PP3, PM2, PM3_very_strong |
Natera, |
RCV000169010 | SCV001453841 | pathogenic | Niemann-Pick disease, type C1 | 2020-09-16 | no assertion criteria provided | clinical testing |